Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children [Phase 4]

View source ↗

Summary

This Phase 4 study assessed safety and immunogenicity of a bivalent killed whole-cell oral cholera vaccine in adults and children; the trial has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Bivalent killed whole-cell oral cholera vaccine

Snippet

Sponsor: International Vaccine Institute | Conditions: Vibrio Cholerae | Phase 4 | Status: COMPLETED